- Home
- OABI vs OTLY Comparison
OABI vs OTLY Comparison
Compare OABI & OTLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OABI
- OTLY
- Stock Information
- Founded
- OABI 2012
- OTLY 1994
- Country
- OABI United States
- OTLY Sweden
- Employees
- OABI N/A
- OTLY N/A
- Industry
- OABI Biotechnology: Pharmaceutical Preparations
- OTLY Packaged Foods
- Sector
- OABI Health Care
- OTLY Consumer Staples
- Exchange
- OABI Nasdaq
- OTLY Nasdaq
- Market Cap
- OABI 307.4M
- OTLY 299.9M
- IPO Year
- OABI N/A
- OTLY 2021
- Fundamental
- Price
- OABI $2.28
- OTLY $9.70
- Analyst Decision
- OABI Strong Buy
- OTLY Buy
- Analyst Count
- OABI 3
- OTLY 4
- Target Price
- OABI $7.00
- OTLY $19.75
- AVG Volume (30 Days)
- OABI 780.2K
- OTLY 118.6K
- Earning Date
- OABI 03-18-2025
- OTLY 04-29-2025
- Dividend Yield
- OABI N/A
- OTLY N/A
- EPS Growth
- OABI N/A
- OTLY N/A
- EPS
- OABI N/A
- OTLY N/A
- Revenue
- OABI $26,391,000.00
- OTLY $823,666,000.00
- Revenue This Year
- OABI $77.72
- OTLY $3.99
- Revenue Next Year
- OABI $30.95
- OTLY $6.21
- P/E Ratio
- OABI N/A
- OTLY N/A
- Revenue Growth
- OABI N/A
- OTLY 5.15
- 52 Week Low
- OABI $2.23
- OTLY $6.00
- 52 Week High
- OABI $5.54
- OTLY $26.80
- Technical
- Relative Strength Index (RSI)
- OABI 27.98
- OTLY 50.43
- Support Level
- OABI $2.38
- OTLY $9.62
- Resistance Level
- OABI $2.57
- OTLY $10.00
- Average True Range (ATR)
- OABI 0.18
- OTLY 0.47
- MACD
- OABI -0.04
- OTLY 0.13
- Stochastic Oscillator
- OABI 4.42
- OTLY 72.95
About OABI OmniAb Inc.
OmniAb Inc offers therapeutic antibody discovery technologies. The company focuses on enabling the rapid development of therapeutics by pushing the frontiers of drug discovery technologies. Its technology platform is designed to enable the efficient discovery of high-quality, fully human antibodies for a wide range of diseases. The heart of the OmniAb technology platform is the Biological Intelligence of its proprietary transgenic animals, including OmniRat, OmniMouse, and OmniChicken, that have been genetically modified to generate antibodies with human sequences which are naturally optimized through in vivo affinity maturation.
About OTLY Oatly Group AB
Oatly Group AB is engaged in the food and drinks industry. Some of its products include Oat Drink, Chilled Oat Drink, Oatgurt, Creamy Oat, and Icecreams, among others. It caters to Sweden, Germany, the United Kingdom, Netherlands, North America, Finland, and Other markets. The company generates revenue from the EMEA, Americas, and Asia regions, with the majority of revenue generated from the EMEA region.